FAKTOR-OPTIONSSCHEIN - AMGEN Stock

DE000SU6TUH3

Market Closed - Boerse Frankfurt Warrants 03:46:25 2024-05-23 pm EDT
0.001 ^EUR	0.00%

1 month	-99.99%
3 months	-99.99%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Amgen : An Underrecognized Risk Factor for Heart Disease	12:22pm	PU
Improving treatment responses to solid tumours with trispecific TCEs	05:31am	AQ
Amgen : From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation	May. 22	PU
Sandoz: Marketing authorization for Wyost and Jubbonti in the EU	May. 22	CF

More news

Quotes 5-day view

Date	Price	Change
24-05-23	0.001	0.00%
24-05-22	0.001	0.00%
24-05-21	0.001	0.00%
24-05-20	0.001	0.00%
24-05-17	0.001	0.00%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 03:46 pm EDT

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Société Générale
WKN	SU6TUH
ISIN	DE000SU6TUH3
Date issued	2024-01-11
Strike	307.2 $
Maturity	Unlimited
Parity	1 : 1
Emission price	10.45 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	24 €
Lowest since issue	0.001 €

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

306.5 USD

Average target price

316.1 USD

Spread / Average Target

+3.12%

Consensus